As 2009 draws to a close, analysts indicate that many plastic and cosmetic surgeons had to endure a loss in revenue due to reduced demand for plastic surgery procedures during the recession. While demand for popular cosmetic procedures such as liposuction, breast implants and facial plastic surgery declined, some aesthetic professionals and surgeons found a steady increase in demand for more affordable options such as Botox, injectable fillers and laser skin resurfacing treatments. Plastic surgery experts have now revealed the industry trends for 2010.
The editors of the Consumer Guide to Plastic Surgery point out that the “Botax” could have a significant negative impact on plastic and cosmetic surgery procedures for the oncoming year, but there will still be a number of treatments that people will be paying a high price for.
One of the emerging trends for 2010 is the addition of more Botox rivals. Dysport, an injectable filler similar to Botox, was introduced to the U.S. market in late 2009 and is priced slightly lower than Botox. It promises the same results and may be a better option for many budget-conscious patients. Other injectables such as PurTox are currently under FDA review and may make their way to the U.S. market by the middle of the year.
Another top trend for 2010 is cryolipolysis, a potential alternative to liposuction. Cryolipolysis involves the freezing of the fat cells to initiate fat cell breakdown. The procedure is currently undergoing trials, but may soon be an attractive option for those that do not want to undergo painful surgery with procedures such as SmartLipo or Vaser Liposelection.
People interested in losing a few inches around their waist are expected to seek procedures such as Zerona, Thermage and VelaShape. Zerona entered U.S. markets in the summer of 2009, and is expected to grow in popularity in 2010.